Qingwutong Health Genetics Files IPO Prospectus, Pioneering Precision Prevention in Chronic Disease Management

Beijing Qingneneneba Wutong Health Technology Co., Ltd. (hereinafter referred to as “Qingwutong Health Genomics”) was established in 2011 as China’s first genetic biotechnology application company dedicated to the “precision prevention” of diseases. In December 2015, Qingwutong officially launched its diabetes product line, which currently provides risk预警, subtype diagnosis, medication guidance, and assisted rehabilitation services for patients with diabetes and their family members. The company aims to integrate genetic testing into everyday life, empowering individuals at risk of chronic diseases or those already affected to better understand disease prevention and control strategies, thereby enabling more effective prevention or treatment.

The Large Population of Diabetes Patients Eagerly Seeks More Information

Currently, Qing Wutong’s products are targeted at individuals with diabetes or suspected diabetes, those at risk of developing the condition in the future, and health-conscious consumers.

According to statistics from the International Diabetes Federation (IDF),2014The number of people with diabetes worldwide (aged 20 to 79) reached 387 million., with nearly 100 million people in China alone. According to statistical data from the National Health and Family Planning Commission in 2015,China has over 260 million patients with chronic diseases, andThe trend of “chronic diseases affecting younger populations” has gradually emerged. On one hand, some patients exhibit an avoidance mentality toward chronic diseases, delaying treatment and allowing mild symptoms to progress into serious conditions. “In fact, for chronic diseases, disease progression can be prevented or reasonably controlled during the preventive stage or early onset,” said Niu Xiaoqiang, founder of Qingwutong Health Genetics, in an interview with VCBeat. On the other hand, patients seeking diagnostic and treatment information face limited channels, preventing them from accessing more effective resources. What Qingwutong is doing involves two main aspects: first, enabling at-risk populations to understand their potential disease risks and take timely preventive measures; second, providing guidance to China’s 114 million diabetic patients to help them understand potential complications, thereby ensuring subsequent treatments are appropriately targeted and enabling more precise, personalized prevention.

Seize the industry's first-mover advantage, form industrial alliances, and become the first to venture into uncharted territory.

Regarding competition within the industry, Niu Xiaoqiang candidly stated that, to date, no company’s diabetes product line is in direct competition with Qing Wutong. Qing Wutong’s strategic focus is on diabetes management within the broader field of chronic disease prevention and control. Currently, multiple companies have established collaborations with Qing Wutong.

Partners of QingwutongPrimarily companies in the field of chronic diseases.The chronic disease industry has a very long value chain, this “Industry Alliance” approach, which involves numerous stakeholders. Some companies or products possess platform attributes, while others do not. Qingwutong does not have platform attributes. Therefore, the optimal strategy is to form an industry alliance.”Among industrial alliances, participants maintain an upstream-downstream relationship, with mutual interdependence that ensures a highly stable structure..” Niu Xiaoqiang mentioned. In its future development, Qingwutong will also collaborate with diabetes communities, pharmaceutical companies, medical device manufacturers, insurance companies, and Grade 3A hospitals to educate the market and promote the overall development of the industry.

The testing methods and price advantages of in vitro diagnostics have helped Qingwutong attract more users.

Qingwutong leverages in vitro diagnostic technologies. After purchasing the product, patients submit samples of blood, saliva, or urine to the company, which then conducts genetic testing and issues a report. This process is simple and rapid, sparing patients the discomfort associated with traditional sampling methods. Additionally, Qingwutong holds a significant price advantage. While large-scale genetic testing companies charge exorbitant fees, averaging RMB 5,000–10,000 per test, Qingwutong offers more affordable pricing at an average of RMB 600 per test. This cost effectiveness enables the general public to easily and quickly undergo testing to obtain their personal health data. Within just two to three months of launch, the number of samples collected by Qingwutong equaled the volume typically gathered by consumer-grade genetic testing companies over one to two years. Currently, Qingwutong offers more than ten products targeting diabetes, such as tests for Type 2 diabetes, Type 2 diabetes complications, and Type 2 diabetes insulin levels. These products cover all age groups and support the entire care continuum, including detection, testing, auxiliary diagnosis, medication guidance, and rehabilitation assistance. Gene therapy is not within Qingwutong’s product scope; specific therapeutic interventions must be conducted by traditional medical institutions.

Advocating for a healthy lifestyle, the founder hopes that Qingwutong can draw more attention to individuals' potential chronic health issues.

Regarding the establishment of the Qingwutong project, Niu Xiaoqiang stated that his personal experiences have given him a profound appreciation for the critical importance of a healthy lifestyle to life itself. As an entrepreneur, he has consistently strived to maintain good dietary habits, ensure sufficient and restorative sleep, and dedicate more time to accompanying his family. “Many people say that I am probably the healthiest founder in the health sector,” Niu Xiaoqiang remarked with a smile.

In ancient times, the phoenix tree was considered a sacred tree, symbolizing health, which is where the name “Qing Wutong” originates. Qing Wutong aims to encourage more people to pay attention to their physical well-being and potential chronic diseases, achieving a healthy lifestyle through adjustments. Niu Xiaoqiang stated, “The essence of precision medicine lies in its accuracy.” In the future, Qing Wutong will increase its investment in enhancing the precision of its products.

Finally, startup teams seeking media coverage are welcome to contact us at:tg@vcbeat.top